BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 17107670)

  • 1. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
    Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice.
    Kirchhof P; Fabritz L; Kilić A; Begrow F; Breithardt G; Kuhn M
    J Mol Cell Cardiol; 2004 May; 36(5):691-700. PubMed ID: 15135664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes.
    Guo T; Zhang T; Mestril R; Bers DM
    Circ Res; 2006 Aug; 99(4):398-406. PubMed ID: 16840718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
    Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
    Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
    Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
    Kilic A; Velic A; De Windt LJ; Fabritz L; Voss M; Mitko D; Zwiener M; Baba HA; van Eickels M; Schlatter E; Kuhn M
    Circulation; 2005 Oct; 112(15):2307-17. PubMed ID: 16216978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes.
    Bartel S; Vetter D; Schlegel WP; Wallukat G; Krause EG; Karczewski P
    J Mol Cell Cardiol; 2000 Dec; 32(12):2173-85. PubMed ID: 11112993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A-dependent phosphorylation of ryanodine receptors increases Ca2+ leak in mouse heart.
    Morimoto S; O-Uchi J; Kawai M; Hoshina T; Kusakari Y; Komukai K; Sasaki H; Hongo K; Kurihara S
    Biochem Biophys Res Commun; 2009 Dec; 390(1):87-92. PubMed ID: 19781523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on recovery during acidosis in cardiac myocytes overexpressing CaMKII.
    Sag CM; Dybkova N; Neef S; Maier LS
    J Mol Cell Cardiol; 2007 Dec; 43(6):696-709. PubMed ID: 17950750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway.
    Wang W; Zhu W; Wang S; Yang D; Crow MT; Xiao RP; Cheng H
    Circ Res; 2004 Oct; 95(8):798-806. PubMed ID: 15375008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
    El-Armouche A; Boknik P; Eschenhagen T; Carrier L; Knaut M; Ravens U; Dobrev D
    Circulation; 2006 Aug; 114(7):670-80. PubMed ID: 16894034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes.
    Kohlhaas M; Zhang T; Seidler T; Zibrova D; Dybkova N; Steen A; Wagner S; Chen L; Brown JH; Bers DM; Maier LS
    Circ Res; 2006 Feb; 98(2):235-44. PubMed ID: 16373600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions.
    Mattiazzi A; Mundiña-Weilenmann C; Guoxiang C; Vittone L; Kranias E
    Cardiovasc Res; 2005 Dec; 68(3):366-75. PubMed ID: 16226237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways.
    Vittone L; Mundiña-Weilenmann C; Said M; Ferrero P; Mattiazzi A
    J Mol Cell Cardiol; 2002 Jan; 34(1):39-50. PubMed ID: 11812163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart.
    Currie S; Loughrey CM; Craig MA; Smith GL
    Biochem J; 2004 Jan; 377(Pt 2):357-66. PubMed ID: 14556649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents.
    Li J; Marionneau C; Zhang R; Shah V; Hell JW; Nerbonne JM; Anderson ME
    Circ Res; 2006 Nov; 99(10):1092-9. PubMed ID: 17038644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
    Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
    Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart.
    Temsah RM; Dyck C; Netticadan T; Chapman D; Elimban V; Dhalla NS
    J Pharmacol Exp Ther; 2000 Apr; 293(1):15-23. PubMed ID: 10734148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.